Publications en collaboration avec des chercheurs de Instituto de Salud Carlos III (24)

2024

  1. GDF15 activates AMPK and inhibits gluconeogenesis and fibrosis in the liver by attenuating the TGF-β1/SMAD3 pathway

    Metabolism: Clinical and Experimental, Vol. 152

2023

  1. Elafibranor upregulates the EMT-inducer S100A4 via PPARβ/δ

    Biomedicine and Pharmacotherapy, Vol. 167

  2. Saturated fatty acid-enriched small extracellular vesicles mediate a crosstalk inducing liver inflammation and hepatocyte insulin resistance

    JHEP Reports, Vol. 5, Núm. 8

  3. Soluble epoxide hydrolase-targeting PROTAC activates AMPK and inhibits endoplasmic reticulum stress

    Biomedicine and Pharmacotherapy, Vol. 168

2022

  1. Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC-induced cholestatic injury by promoting a pro-restorative inflammatory response

    Journal of Pathology, Vol. 258, Núm. 3, pp. 312-324

2021

  1. Increased hypothalamic anti‐inflammatory mediators in non‐diabetic insulin receptor substrate 2‐deficient mice

    Cells, Vol. 10, Núm. 8

  2. Metformin reduces macrophage HIF1α-dependent proinflammatory signaling to restore brown adipocyte function in vitro

    Redox Biology, Vol. 48

2020

  1. Effect of topical administration of somatostatin on retinal inflammation and neurodegeneration in an experimental model of diabetes

    Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-18

  2. Moderate SIRT1 overexpression protects against brown adipose tissue inflammation

    Molecular Metabolism, Vol. 42

2019

  1. Second-generation antipsychotics and dysregulation of glucose metabolism: Beyond weight gain

    Cells, Vol. 8, Núm. 11

2018

  1. Dual role of protein tyrosine phosphatase 1B in the progression and reversion of non-alcoholic steatohepatitis

    Molecular Metabolism, Vol. 7, pp. 132-146

2016

  1. Autophagy resolves early retinal inflammation in Igf1-deficient mice

    DMM Disease Models and Mechanisms, Vol. 9, Núm. 9, pp. 965-974

  2. Corrigendum to "IRS2 and PTEN are key molecules in controlling insulin sensitivity in podocytes" [Biochim. Biophys. Acta 1853 (12) (2015) 3224-3234] doi 10.1016/j.bbamcr.2015.09.020

    Biochimica et Biophysica Acta - Molecular Cell Research

  3. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  4. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  5. Increased oxidative stress and apoptosis in the hypothalamus of diabetic male mice in the insulin receptor substrate-2 knockout model

    DMM Disease Models and Mechanisms, Vol. 9, Núm. 5, pp. 573-583

  6. Rapamycin negatively impacts insulin signaling, glucose uptake and uncoupling protein-1 in brown adipocytes

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1861, Núm. 12, pp. 1929-1941

  7. Single administration of recombinant IL-6 restores the gene expression of lipogenic enzymes in liver of fasting IL-6-deficient mice

    British Journal of Pharmacology, Vol. 173, Núm. 6, pp. 1070-1084

2015

  1. Essential role of Nrf2 in the protective effect of lipoic acid against lipoapoptosis in hepatocytes

    Free Radical Biology and Medicine, Vol. 84, pp. 263-278

  2. IRS2 and PTEN are key molecules in controlling insulin sensitivity in podocytes

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1853, Núm. 12, pp. 3224-3234